Loading...

FITC anti-mouse CD3 Antibody

Pricing & Availability
Clone
17A2 (See other available formats)
Regulatory Status
RUO
Other Names
T cell antigen receptor complex, T3
Isotype
Rat IgG2b, κ
Ave. Rating
Submit a Review
Product Citations
publications
17A2
C57BL/6 splenocytes stained with 17A2 FITC and 145-2C11 PE
  • 17A2
    C57BL/6 splenocytes stained with 17A2 FITC and 145-2C11 PE
Compare all formats See FITC spectral data
Cat # Size Price Quantity Check Availability Save
100203 50 µg 29€
Check Availability


Need larger quantities of this item?
Request Bulk Quote
100204 500 µg 115€
Check Availability


Need larger quantities of this item?
Request Bulk Quote
Description

CD3, also known as T3, is a member of the Ig superfamily and primarily expressed on T cells, NK-T cells, and at different levels on thymocytes during T cell differentiation. CD3 is composed of CD3ε, δ, γ and ζ chains. It forms a TCR complex by associating with TCR α/β or γ/δ chains. CD3 plays a critical role in TCR signal transduction, T cell activation, and antigen recognition by binding the peptide/MHC antigen complex

Product Details
Technical Data Sheet (pdf)

Product Details

Verified Reactivity
Mouse
Antibody Type
Monoclonal
Host Species
Rat
Immunogen
γδTCR-positive T-T hybridoma D1
Formulation
Phosphate-buffered solution, pH 7.2, containing 0.09% sodium azide.
Preparation
The antibody was purified by affinity chromatography, and conjugated with FITC under optimal conditions.
Concentration
0.5 mg/ml
Storage & Handling
The antibody solution should be stored undiluted between 2°C and 8°C, and protected from prolonged exposure to light. Do not freeze.
Application

FC - Quality tested
Recommended Usage

Each lot of this antibody is quality control tested by immunofluorescent staining with flow cytometric analysis. For flow cytometric staining, the suggested use of this reagent is ≤1.0 µg per million cells in 100 µl volume. It is recommended that the reagent be titrated for optimal performance for each application.

Excitation Laser
Blue Laser (488 nm)
Application Notes

Additional reported application (for relevant formats) include: spatial biology (IBEX)1,2.

Application References

(PubMed link indicates BioLegend citation)
  1. Radtke AJ, et al. 2020. Proc Natl Acad Sci U S A. 117:33455-65. (SB) PubMed
  2. Radtke AJ, et al. 2022. Nat Protoc. 17:378-401. (SB) PubMed
Product Citations
  1. Harsha Krovi S, et al. 2020. Nat Commun. 4.790277778. PubMed
  2. Dai L, et al. 2020. Cell. 182(3):722-733.e11. PubMed
  3. Xing J, et al. 2021. Cell Reports. 35(12):109205. PubMed
  4. Zaman R, et al. 2021. Immunity. :. PubMed
  5. Yu X, et al. 2020. Nat Commun. 11:1110. PubMed
  6. Jiang W, et al. 2017. Sci Rep. 7:6501. PubMed
  7. Petrova T, et al. 2020. Sci Rep. 10:3479. PubMed
  8. Zhang H, et al. 2021. Front Immunol. 12:644520. PubMed
  9. Garo LP, et al. 2021. Nat Commun. 12:2419. PubMed
  10. Lee JH, et al. 2022. EBioMedicine. 77:103903. PubMed
  11. Zhu Y, et al. 2022. Nat Commun. 13:4282. PubMed
  12. Harel M, et al. 2020. J Immunol. 205:1167. PubMed
  13. Bruno MEC, et al. 2022. J Cell Physiol. 237:706. PubMed
  14. Pei J, et al. 2022. J Virol. 96:e0194221. PubMed
  15. Li X, et al. 2022. J Clin Invest. 132: . PubMed
  16. Meng J, et al. 2022. Cell Rep. 38:110492. PubMed
  17. Corral D, et al. 2022. Cell Rep. 39:110715. PubMed
  18. Yue Y, et al. 2022. Nat Biomed Eng. 6:898. PubMed
  19. Brog RA, et al. 2022. Cancer Immunol Res. 10:962. PubMed
  20. Wu J, et al. 2023. Bioact Mater. 20:259. PubMed
  21. Shen CY, et al. 2022. Pharmaceutics. 14: . PubMed
  22. Brigo N, et al. 2022. Bio Protoc. 12:e4440. PubMed
  23. Hong Y, et al. 2022. J Leukoc Biol. 112:425. PubMed
  24. Mugarza E, et al. 2022. Sci Adv. 8:eabm8780. PubMed
  25. Xie DH, et al. 2022. Med Phys. 49:6728. PubMed
  26. Gong F, et al. 2023. Adv Healthc Mater. 12:e2201771. PubMed
  27. Gao Y, et al. 2022. Cell Res. 32:1086. PubMed
  28. Chen Y, et al. 2023. Adv Healthc Mater. 12:e2202085. PubMed
  29. Wei M, et al. 2022. Front Immunol. 13:1017574. PubMed
  30. Liang Y, et al. 2022. Theranostics. 12:7729. PubMed
  31. You Q, et al. 2023. Adv Mater. 35:e2204910. PubMed
  32. Kim HI, et al. 2022. Molecules. 27: . PubMed
  33. Shi C, et al. 2023. Nat Nanotechnol. 18:86. PubMed
  34. Yang H, et al. 2023. Cell Death Differ. 30:560. PubMed
  35. Yu J, et al. 2022. Nat Commun. 13:7903. PubMed
  36. Schepers M, et al. 2023. Brain Behav Immun. 109:1. PubMed
  37. Ding L, et al. 2023. J Clin Invest. 133: . PubMed
  38. Peng Q, et al. 2023. EMBO Rep. 24:e56034. PubMed
  39. Jin SM, et al. 2023. Nat Nanotechnol. :. PubMed
  40. Liu H, et al. 2023. Cell Death Differ. :. PubMed
  41. Tsioti I, et al. 2023. J Neuroinflammation. 20:25. PubMed
  42. Gon Y, et al. 2023. PLoS One. 18:e0279389. PubMed
  43. Wang L, et al. 2023. Oxid Med Cell Longev. 2023:6480848. PubMed
  44. Zhang W, et al. 2022. Dev Cell. 57:329. PubMed
  45. Meacham CE, et al. 2022. Nat Cell Biol. 24:697. PubMed
  46. Reticker-Flynn NE, et al. 2022. Cell. 185:1924. PubMed
  47. Bruggemann TR, et al. 2022. iScience. 25:105185. PubMed
  48. Zimmerman SM, et al. 2022. Oncogene. 41:4983. PubMed
  49. Peng J, et al. 2023. Am J Reprod Immunol. 89:e13678. PubMed
  50. Chen H, et al. 2023. Nat Commun. 14:941. PubMed
  51. Wang F, et al. 2023. Int J Mol Sci. 24:. PubMed
  52. Liu HJ, et al. 2023. Nat Commun. 14:1214. PubMed
  53. Guo D, et al. 2023. Cell Biosci. 13:51. PubMed
  54. Dang YZ, et al. 2023. Neoplasma. 70:123. PubMed
  55. Wang Y, et al. 2023. Front Bioeng Biotechnol. 11:1128268. PubMed
  56. Sambandam A, et al. 2023. Heliyon. 9:e14238. PubMed
  57. Masle-Farquhar E, et al. 2023. Front Immunol. 14:1095257. PubMed
  58. Tao Q, et al. 2023. Microbiol Spectr. :e0522922. PubMed
  59. Tan X, et al. 2023. Adv Sci (Weinh). 10:e2206768. PubMed
  60. Zhang YN, et al. 2023. Nat Commun. 14:1985. PubMed
  61. Ito M, et al. 2023. Sci Rep. 13:5939. PubMed
  62. Huang T, et al. 2023. Front Immunol. 14:1124152. PubMed
  63. Kuang C, et al. 2023. Nat Commun. 14:2093. PubMed
  64. Zuo B, et al. 2023. Clin Transl Oncol. . PubMed
  65. Bhaskar A, et al. 2023. iScience. 26:106644. PubMed
  66. Wang K, et al. 2023. Nat Commun. 14:2950. PubMed
  67. Wang D, et al. 2023. Nat Commun. 14:2943. PubMed
  68. Xie J, et al. 2023. Mol Ther Oncolytics. 29:61. PubMed
  69. Feng X, et al. 2023. Nat Commun. 14:3208. PubMed
  70. Zeng S, et al. 2023. Front Oncol. 13:1171926. PubMed
  71. Lan Y, et al. 2023. iScience. 26:106817. PubMed
  72. Yang QC, et al. 2023. iScience. 26:106916. PubMed
  73. Miller CM, et al. 2020. J Virol. 94:00:00. PubMed
  74. Boyd DF, et al. 2020. Nature. 587:466. PubMed
  75. Wu X, et al. 2012. Biochem Pharmacol. 84:1164. PubMed
  76. Lin W, et al. 2020. Theranostics. 10:4871. PubMed
  77. Gawish R, et al. 2022. Elife. 11:. PubMed
  78. Qiao Y, et al. 2021. Oncoimmunology. 10:1947569. PubMed
  79. Li Q, et al. 2022. Cell Rep. 40:111308. PubMed
  80. Manukian G, et al. 2021. Int J Radiat Oncol Biol Phys. 110:1341. PubMed
  81. Jiang Q, et al. 2022. Theranostics. 12:59. PubMed
  82. Wilhelm J, et al. 2021. J Control Release. 329:353. PubMed
  83. Ford K, et al. 2020. Cancer Res. 80:1846. PubMed
  84. Delvecchio FR, et al. 2021. Cell Mol Gastroenterol Hepatol. 12:1543. PubMed
  85. Zhang R, et al. 2021. Cell Mol Immunol. 18:1222. PubMed
  86. Tang L, et al. 2021. Oncol Lett. 22:605. PubMed
  87. Kim D, et al. 2021. Nanomicro Lett. 13:31. PubMed
  88. Bao H, et al. 2020. Mol Med Rep. 4.675. PubMed
  89. Du Q, et al. 2019. Front Microbiol. 10:2050. PubMed
  90. Song C, et al. 2019. Nat Commun. 10:3745. PubMed
  91. Liu QZ, et al. 2018. Front Immunol. 1.131944444. PubMed
  92. Chou YJ, et al. 2020. Sci Rep. 10:8422. PubMed
  93. Bromley SK, et al. 2020. Cell Reports. 32(9):108085. PubMed
  94. Turner JA, et al. 2020. Immunity. 53:1202. PubMed
  95. Jiang W, et al. 2021. Oncol Lett. 22:625. PubMed
  96. Choi YY, et al. 2021. Cell Death Dis. 12:826. PubMed
  97. Almeida AS, et al. 2021. Bio Protoc. 11:e4012. PubMed
  98. Zhang S, et al. 2022. Acta Pharm Sin B. 12:3124. PubMed
  99. Steubing RD, et al. 2022. Brain Behav Immun Health. 24:100493. PubMed
  100. Mei S, et al. 2022. Front Immunol. 13:911164. PubMed
  101. Lu H, et al. 2021. Autophagy. 17:2511. PubMed
  102. Fu Y, et al. 2020. Mol Ther. 1214:28. PubMed
  103. Sun CC, et al. 2020. Genome Med. 0.553472222. PubMed
  104. Schmidleithner L et al. 2019. Immunity. 50(5):1232-1248 . PubMed
  105. Diao L, et al. 2022. iScience. 25:105511. PubMed
  106. Bangs DJ, et al. 2022. Cell Rep. 38:110266. PubMed
  107. Huang Y, et al. 2021. Radiother Oncol. 162:34. PubMed
  108. Zhao J, et al. 2022. J Nanobiotechnology. 20:62. PubMed
  109. Ren J, et al. 2021. Theranostics. 11:304. PubMed
  110. Tan X, et al. 2021. Front Oncol. 11:768222. PubMed
  111. Oliva Chávez AS, et al. 2021. Nat Commun. 12:3696. PubMed
  112. Liu Q, et al. 2021. Cell Death Dis. 12:240. PubMed
  113. Starkl P, et al. 2020. Immunity. 53(4):793-804.e9. PubMed
  114. Antonia O Cuff et al. 2017. Wellcome open research. 2:39 . PubMed
  115. Davis FM, et al. 2019. Arterioscler Thromb Vasc Biol. 39:2353. PubMed
  116. Pham THM, et al. 2020. Cell Host & Microbe. 27(1):54-67.e5.. PubMed
  117. Lesmeister M, et al. 2005. Reprod Biol Endocrinol. 29:74. PubMed
  118. Dolgova EV, et al. 2022. Int J Mol Sci. 23:. PubMed
  119. Mostafavi H, et al. 2022. PLoS Pathog. 18:e1010185. PubMed
  120. Sala D, et al. 2022. Mol Ther Methods Clin Dev. 25:170. PubMed
  121. Yu AI, et al. 2020. Cell Rep. 107471:31. PubMed
  122. Jiang S, et al. 2020. Scand J Immunol. e12867:91. PubMed
  123. Perner C, et al. 2020. Immunity. 53(5):1063-1077.e7. PubMed
  124. White C, et al. 2014. J Immunol. 193:5933. PubMed
  125. Chen Y, et al. 2012. PLoS One. 7:e47190. PubMed
  126. Ning X, et al. 2019. Mol Cell. 74:19. PubMed
  127. Uchimura T et al. 2018. Immunity. 49(6):1049-1061 . PubMed
  128. Deng P, et al. 2022. Cells. 11:. PubMed
  129. Li Y, et al. 2022. Clin Transl Immunology. 11:e1362. PubMed
  130. Zhan Y, et al. 2021. JCI Insight. 6:. PubMed
  131. Lee M, et al. 2014. PLoS One. 9:112666. PubMed
  132. Mingozzi F, et al. 2016. EMBO Mol Med. 8: 1039 - 1051. PubMed
  133. Solanki A, et al. 2018. Development. 145. PubMed
  134. Shields BD, et al. 2019. Cancer Res. 79:1113. PubMed
  135. Dang Y, et al. 2022. Cancer Cell Int. 22:88. PubMed
  136. Almeida AS, et al. 2021. Bio Protoc. 11:e4012. PubMed
  137. Geng T, et al. 2022. Methods Mol Biol. 2585:71. PubMed
  138. Park HB, et al. 2020. Oncoimmunology. 9:1772663. PubMed
  139. Kimball AS et al. 2019. Immunity. 51(2):258-271 . PubMed
  140. Naing A et al. 2019. Cell reports. 26(5):1242-1257 . PubMed
  141. Yang S, et al. 2019. Nat Commun. 10:2782. PubMed
  142. Carr RM, et al. 2021. Nat Commun. 12:2901. PubMed
  143. Pervaiz N, et al. 2021. Pigment Cell Melanoma Res. 34:918. PubMed
  144. Sun Y, et al. 2022. Nat Commun. 13:3916. PubMed
  145. Zhang B, et al. 2021. Nat Biomed Eng. 5:1288. PubMed
  146. Chen Q, et al. 2016. Nat Commun. 7:13193. PubMed
  147. Bogie JF, et al. 2020. Ther Adv Chronic Dis. 11:2040622320947378. PubMed
  148. Li Y, et al. 2020. Cell Stem Cell. 27(5):732-747.e7. PubMed
  149. Omori S, et al. 2021. Cell Reports. 34(6):108734. PubMed
  150. Wang X, et al. 2018. Mol Med Rep. 17:1660. PubMed
  151. Lee JS et al. 2018. Cell. 174(6):1559-1570 . PubMed
  152. Comazzetto S et al. 2018. Cell stem cell. 24(3):477-486 . PubMed
  153. Littwitz-Salomon E, et al. 2021. Nat Commun. 12:5376. PubMed
  154. Hanasoge Somasundara AV, et al. 2021. Cell Rep. 37:110099. PubMed
  155. Shi R, et al. 2022. Theranostics. 12:875. PubMed
  156. Jie X, et al. 2022. J Immunother Cancer. 10:. PubMed
  157. Harb H, et al. 2021. Immunity. 54(6):1186-1199.e7. PubMed
  158. Tacconi C, et al. 2021. Cell Reports. 35(2):108993. PubMed
  159. Elahi S, et al. 2020. Stem Cell Res. 43:101710. PubMed
  160. Akhter N, et al. 2016. J Biol Chem. 291: 23672 - 23680. PubMed
  161. Huang B, et al. 2015. PLoS One. 10: 0134715. PubMed
  162. Markey K, et al. 2014. J Immunol. 192:5426. PubMed
  163. Sreekumar PG, et al. 2018. J Control Release. 283:94. PubMed
  164. Garo LP, et al. 2019. Cell Rep. 28:3353. PubMed
  165. Li W, et al. 2019. Nat Commun. 10:3349. PubMed
  166. Xu X, et al. 2018. Cell. 175:1336. PubMed
  167. Reismann D, et al. 2017. Nat Commun.. 10.1038/s41467-017-01538-9. PubMed
  168. Ishidome T et al. 2017. EBioMedicine. 22:89-99 . PubMed
  169. Ding Y, et al. 2022. Cell Death Dis. 13:996. PubMed
  170. Tang X, et al. 2022. Cell Rep. 41:111673. PubMed
  171. Wei W, et al. 2022. mSystems. 7:e0046922. PubMed
  172. Zhao X, et al. 2022. Nat Protoc. 17:2240. PubMed
  173. Zhou H, et al. 2022. Oncoimmunology. 11:2057892. PubMed
  174. Yang J, et al. 2022. Microbiome. 10:149. PubMed
  175. Harnett MM, et al. 2022. Front Immunol. 13:953053. PubMed
  176. Koren E, et al. 2022. Nat Commun. 13:4628. PubMed
  177. Zhang C, et al. 2022. Nat Commun. 13:3468. PubMed
  178. Chen X, et al. 2021. Cell Rep. 37:109991. PubMed
  179. Ye P, et al. 2022. Front Cardiovasc Med. 8:810477. PubMed
  180. Zuo S, et al. 2021. J Immunother Cancer. 9:. PubMed
  181. Reinfeld BI, et al. 2021. Nature. 593:282. PubMed
  182. Du J, et al. 2012. Stem Cells. 30:1447. PubMed
  183. Weinheimer-Haus E, et al. 2014. PLoS One. 9:91355. PubMed
  184. Zheng L, et al. 2020. Front Oncol. 10:531131. PubMed
  185. Kruta M, et al. 2021. Cell Stem Cell. :. PubMed
  186. Moon HG et al. 2018. Immunity. 49(2):275-287 . PubMed
  187. Ren W, et al. 2018. Mucosal Immunol. 12:531. PubMed
  188. Liu W, et al. 2021. Cell Death Discov. 7:136. PubMed
  189. França TT, et al. 2021. JCI Insight. 6:. PubMed
  190. Carbone C, et al. 2021. J Immunother Cancer. 9:. PubMed
  191. Shannon JP, et al. 2021. STAR Protoc. 2:100790. PubMed
  192. Sun C, et al. 2022. J Adv Res. 35:71. PubMed
  193. Alsina-Sanchis E, et al. 2020. Mol Cancer Res. . PubMed
  194. Shannon JP, et al. 2021. Immunity. 54(2):276-290.e5. PubMed
  195. Choi EW, et al. 2020. Sci Rep. 10:12001. PubMed
  196. Yu X, et al. 2019. Nat Commun. 10:574. PubMed
  197. Cohen M et al. 2018. Cell. 175(4):1031-1044 . PubMed
  198. Ma W, et al. 2017. Cell Death & Disease. 10.1038/cddis.2017.47. PubMed
  199. Yang Z, et al. 2021. Onco Targets Ther. 14:4239. PubMed
  200. Puigdelloses M, et al. 2021. J Immunother Cancer. 9:. PubMed
  201. Frost JN, et al. 2021. Med (N Y). 2:164. PubMed
  202. Port JR, et al. 2020. J Virol. 94:. PubMed
  203. Rashid MH, et al. 2021. Oncol Rep. 45:1171. PubMed
  204. Li Y, et al. 2021. Cell Death Dis. 12:1001. PubMed
  205. Zhang W, et al. 2019. Mar Drugs. 0.845138889. PubMed
  206. Nowlan B, et al. 2019. Haematologica. 105:71. PubMed
  207. Zhang W, et al. 2020. Nat Commun. 11:1187. PubMed
  208. Yu H, et al. 2021. Front Oncol. 11:736882. PubMed
  209. Xiao Y, et al. 2022. Nat Commun. 13:758. PubMed
  210. Zhang R, et al. 2022. Front Pharmacol. 13:870848. PubMed
  211. Ali S, et al. 2021. PLoS One. 16:e0246646. PubMed
  212. Yang Z, et al. 2021. Nat Commun. 12:4852. PubMed
  213. Pandit M, et al. 2021. Eur J Immunol. 51:1461. PubMed
  214. Lingegowda H, et al. 2022. Front Reprod Health. 3:726936. PubMed
  215. Wang Z, et al. 2021. Acta Pharm Sin B. 694:11. PubMed
  216. Chen R, et al. 2021. Cell Reports. 34(7):108751. PubMed
  217. Wu L, et al. 2020. Cell Rep. 33:108327. PubMed
  218. Zan H, et al. 2017. Nat Commun. 8:14244. PubMed
  219. Cabrera-Perez J, et al. 2016. J Immunol. 197: 1692 - 1698. PubMed
  220. Kang J, Lee J, Chang J 2016. PLoS One. 11: 0157015. PubMed
  221. Cabrera-Perez C, et al. 2015. J Immunol . 194:1609-20. PubMed
  222. He J, et al. 2020. Evid Based Complement Alternat Med. 2020:5637507. PubMed
  223. Roy S, et al. 2019. Front Immunol. 2.404166667. PubMed
  224. Scally S, et al. 2017. Nat Commun. . 10.1038/s41467-017-01924-3. PubMed
  225. Yi H, et al. 2021. Front Immunol. 12:719189. PubMed
  226. Qi J, et al. 2021. Nat Commun. 12:4755. PubMed
  227. Bent EH, et al. 2021. Nat Commun. 12:6218. PubMed
  228. Zhang YN, et al. 2021. Sci Adv. 7:eabj3107. PubMed
  229. Murdock BJ, et al. 2021. JCI Insight. 6:. PubMed
  230. Robertson TF, et al. 2021. J Cell Biol. 220:. PubMed
  231. Mohammadi MR, et al. 2021. Commun Biol. 4:685. PubMed
  232. Li X, et al. 2021. Cell Death Dis. 12:314. PubMed
  233. Chen X, et al. 2019. Med Sci Monit. 25:5389. PubMed
  234. Zhang X, et al. 2021. Nat Commun. 12:4536. PubMed
  235. Smith-Díaz CC, et al. 2021. Front Oncol. 11:709543. PubMed
  236. Tsai HI, et al. 2021. EMBO Mol Med. 13:e12834. PubMed
  237. Wang J, et al. 2022. Clin Transl Med. 12:e718. PubMed
  238. Lai Y, et al. 2022. Clin Transl Med. 12:e999. PubMed
  239. Zhang J, et al. 2022. Biomater Res. 26:44. PubMed
  240. Li M, et al. 2021. Br J Pharmacol. 178:2617. PubMed
  241. Yang YS, et al. 2022. Nat Commun. 13:6175. PubMed
  242. Harb H, et al. 2020. Nat Immunol. 1359:21. PubMed
  243. Campolo M, et al. 2020. Int J Mol Sci. 21:00. PubMed
  244. Baumann D, et al. 2020. Nat Commun. 1.969444444. PubMed
  245. Chen C, et al. 2020. Front Cell Neurosci. 14:8. PubMed
  246. Clemente–Casares X, et al. 2017. Immunity. 47:974. PubMed
  247. Chen Y, et al. 2022. Nat Commun. 13:4468. PubMed
  248. Nam J, et al. 2021. Adv Ther (Weinh). 4:. PubMed
  249. Leary N, et al. 2022. J Extracell Vesicles. 11:e12197. PubMed
  250. Zhou H, et al. 2021. Cell Death Discov. 7:332. PubMed
  251. Yang Z, et al. 2021. Nat Commun. 12:4299. PubMed
  252. van den Berk P, et al. 2020. Cell Rep. 33:108533. PubMed
  253. Xu Y, et al. 2016. Nat Commun. 7:12073. PubMed
  254. Zheng DW, et al. 2020. Nat Commun. 3.865972222. PubMed
  255. Jia H, et al. 2018. Int J Oncol. 53:949. PubMed
  256. Chao Y, et al. 2020. Sci Adv. 6:eaaz4204. PubMed
  257. Jiang Y, et al. 2021. Nat Commun. 12:742. PubMed
  258. Magee JA, et al. 2021. Stem Cell Reports. 16:20. PubMed
  259. Fujimoto M, et al. 2022. Nat Commun. 13:5408. PubMed
  260. Cané S, et al. 2021. J Immunother Cancer. 9:. PubMed
  261. Ravindran Menon D, et al. 2021. Pharmaceuticals (Basel). 14:. PubMed
  262. Le QV, et al. 2022. Bioact Mater. 15:160. PubMed
  263. Aulova KS, et al. 2022. Molecules. 27:. PubMed
  264. Yang N, et al. 2022. Nat Commun. 13:2336. PubMed
  265. Guo X, et al. 2020. J Cell Mol Med. . PubMed
  266. Simoni L, et al. 2020. Cell Rep. 33:108330. PubMed
  267. Yu H, et al. 2015. PLoS One. 10: 0143001. PubMed
  268. Pan X, et al. 2019. BMC Complement Altern Med. 19:163. PubMed
  269. Li K, et al. 2020. Nat Commun. 0.795138889. PubMed
  270. Hidalgo San Jose L, et al. 2020. Cell Rep. 30:69. PubMed
  271. Zukauskas A, et al. 2018. mSphere. 3:e00303. PubMed
  272. Tao Z, et al. 2022. Cells. 11:. PubMed
  273. Tang T, et al. 2022. J Immunother Cancer. 10:. PubMed
  274. Zhou Y, et al. 2022. Theranostics. 12:5488. PubMed
  275. Chen LH, et al. 2021. Sci Rep. 11:19478. PubMed
  276. Liu X, et al. 2021. Adv Sci (Weinh). 8:e2100233. PubMed
  277. Wang J, et al. 2021. Am J Cancer Res. 11:2005. PubMed
  278. Wang F, et al. 2021. Neoplasia. 23:281. PubMed
  279. Roberto MP, et al. 2021. Immunity. 54(8):1807-1824.e14. PubMed
  280. Goldberg EL, et al. 2021. Cell Metabolism. :. PubMed
  281. Tanegashima K et al. 2017. EBioMedicine. 24:247-256 . PubMed
  282. Crowe J, et al. 2020. PLoS Pathog. 16:e1008391. PubMed
  283. Tur J, et al. 2020. Cell Reports. 32(8):108079. PubMed
  284. Mincham KT, et al. 2021. Front Immunol. 11:601494. PubMed
  285. Zheng Y, et al. 2022. Transl Res. :. PubMed
  286. Gawish R, et al. 2022. Elife. 11:. PubMed
  287. Li J, et al. 2022. Nat Commun. 13:1481. PubMed
  288. Li J, et al. 2021. eLife. 10:00. PubMed
  289. Trivedi S, et al. 2020. Elife. 9:00. PubMed
  290. Tripathi D, et al. 2016. Nat Commun. 7:13896. PubMed
  291. Fan X, et al. 2014. PLoS One. 9:107638. PubMed
  292. Martínez-Vicente P, et al. 2019. PLoS Pathog. 15:e1007658. PubMed
  293. Liu WL, et al. 2019. Nat Commun. 10:3199. PubMed
  294. Kubli SP, et al. 2019. Nat Commun. 10:2678. PubMed
  295. Sun Q, et al. 2022. J Inflamm Res. 15:5827. PubMed
  296. Cao Y, et al. 2022. Small. 18:e2203466. PubMed
  297. Li C, et al. 2022. Front Cell Dev Biol. 10:913824. PubMed
  298. Xu Z, et al. 2022. Cell Death Dis. 13:502. PubMed
  299. Pastor Arroyo EM, et al. 2022. Clin Sci (Lond). 136:557. PubMed
  300. Erens C, et al. 2022. Biomedicines. 10:. PubMed
  301. Zhang J, et al. 2021. Stem Cell Res Ther. 12:579. PubMed
  302. Gu Z, et al. 2021. Nat Genet. 53:672. PubMed
  303. Zuo S, et al. 2021. EBioMedicine. 64:103240. PubMed
  304. Zheng QY, et al. 2020. FASEB J. 34:10590. PubMed
RRID
AB_312661 (BioLegend Cat. No. 100203)
AB_312661 (BioLegend Cat. No. 100204)

Antigen Details

Structure
Ig superfamily, CD3/TCR, 20 kD
Distribution

Thymocytes (differentiation dependent), mature T cells, NK-T cells

Function
Antigen recognition, TCR signal transduction, T cell activation
Ligand/Receptor
Peptide antigen/MHC-complex
Antigen References

1. Barclay A, et al. 1997. The Leukocyte Antigen FactsBook Academic Press.
2. Davis MM. 1990. Annu. Rev. Biochem. 59:475.
3. Weiss A, et al. 1994. Cell 76:263.

Gene ID
12502 View all products for this Gene ID
UniProt
View information about CD3 on UniProt.org

Other Formats

View All CD3 Reagents Request Custom Conjugation
Description Clone Applications
FITC anti-mouse CD3 17A2 FC
PE anti-mouse CD3 17A2 FC
Purified anti-mouse CD3 17A2 FC,IHC-F,IP,ICC
Alexa Fluor® 647 anti-mouse CD3 17A2 FC,IHC-F,3D IHC,SB
Alexa Fluor® 488 anti-mouse CD3 17A2 FC,IHC-F,3D IHC
Pacific Blue™ anti-mouse CD3 17A2 FC
Alexa Fluor® 700 anti-mouse CD3 17A2 FC
PerCP/Cyanine5.5 anti-mouse CD3 17A2 FC
PE/Cyanine7 anti-mouse CD3 17A2 FC
APC/Cyanine7 anti-mouse CD3 17A2 FC
Brilliant Violet 421™ anti-mouse CD3 17A2 FC,ICC
Brilliant Violet 570™ anti-mouse CD3 17A2 FC
Brilliant Violet 650™ anti-mouse CD3 17A2 FC
Brilliant Violet 785™ anti-mouse CD3 17A2 FC
Brilliant Violet 510™ anti-mouse CD3 17A2 FC
APC anti-mouse CD3 17A2 FC
Ultra-LEAF™ Purified anti-mouse CD3 17A2 FC,IHC-F,IP,ICC
Brilliant Violet 605™ anti-mouse CD3 17A2 FC
Alexa Fluor® 594 anti-mouse CD3 17A2 IHC-F,FC,3D IHC,SB
Brilliant Violet 711™ anti-mouse CD3 17A2 FC
Biotin anti-mouse CD3 17A2 FC,IHC-F
PE/Dazzle™ 594 anti-mouse CD3 17A2 FC
APC/Fire™ 750 anti-mouse CD3 17A2 FC
Brilliant Violet 750™ anti-mouse CD3 17A2 FC
TotalSeq™-A0182 anti-mouse CD3 17A2 PG
TotalSeq™-B0182 anti-mouse CD3 17A2 PG
Spark Blue™ 550 anti-mouse CD3 17A2 FC
Spark NIR™ 685 anti-mouse CD3 17A2 FC
TotalSeq™-C0182 anti-mouse CD3 17A2 PG
APC/Fire™ 810 anti-mouse CD3 17A2 FC
PE/Fire™ 640 anti-mouse CD3 17A2 FC
Spark YG™ 570 anti-mouse CD3 17A2 IHC-F
PE/Fire™ 700 anti-mouse CD3 17A2 FC
PE/Cyanine5 anti-mouse CD3 17A2 FC
Spark Blue™ 574 anti-mouse CD3 Antibody 17A2 FC
Spark Violet™ 423 anti-mouse CD3 17A2 FC
PE/Fire™ 810 anti-mouse CD3 17A2 FC
Spark Red™ 718 anti-mouse CD3 17A2 FC
Spark UV™ 387 anti-mouse CD3 17A2 FC
Go To Top Version: 1    Revision Date: 11.30.2012

For Research Use Only. Not for diagnostic or therapeutic use.

 

This product is supplied subject to the terms and conditions, including the limited license, located at www.biolegend.com/terms) ("Terms") and may be used only as provided in the Terms. Without limiting the foregoing, BioLegend products may not be used for any Commercial Purpose as defined in the Terms, resold in any form, used in manufacturing, or reverse engineered, sequenced, or otherwise studied or used to learn its design or composition without express written approval of BioLegend. Regardless of the information given in this document, user is solely responsible for determining any license requirements necessary for user’s intended use and assumes all risk and liability arising from use of the product. BioLegend is not responsible for patent infringement or any other risks or liabilities whatsoever resulting from the use of its products.

 

BioLegend, the BioLegend logo, and all other trademarks are property of BioLegend, Inc. or their respective owners, and all rights are reserved.

 

8999 BioLegend Way, San Diego, CA 92121 www.biolegend.com
Toll-Free Phone: 1-877-Bio-Legend (246-5343) Phone: (858) 768-5800 Fax: (877) 455-9587

This data display is provided for general comparisons between formats.
Your actual data may vary due to variations in samples, target cells, instruments and their settings, staining conditions, and other factors.
If you need assistance with selecting the best format contact our expert technical support team.

ProductsHere
Login / Register
Remember me
Forgot your password? Reset password?
Create an Account